The health trial by researchers at the University of Southern Denmark has been suspended by Bissau-Guinean authorities.

Guinea-Bissau’s political crisis is deepening. The country’s main opposition leader, Domingos Simões Pereira, has been ...

DAKAR, Senegal (AP) — Guinea-Bissau is suspending a Trump administration-backed hepatitis B vaccine study on newborns in the West African country, pending an ethical review, the health minister said ...

DAKAR, Senegal (AP) — In West Africa’s latest military takeover, soldiers in Guinea-Bissau followed up a disputed presidential election by seizing power last week in what some critics allege was a ...

The U.S. Centers for Disease Control and Prevention (CDC) approved a $1.6 million grant to fund a study on the efficacy of the hepatitis B vaccine Dec. 15, 2025. After U.S. Secretary of Health ...

African scientists have criticised a study of hepatitis B virus birth dose vaccination as being unethical. Gilbert Nakweya reports.

BISSAU, Feb. 4 (Xinhua) -- The transitional government of Guinea-Bissau said the high military command, which has been running the country since the Nov. 26 coup, will "unequivocally" respect the ...

Guinea-Bissau opposition leader Domingos Simões Pereira faces a military court over allegations of involvement in multiple coup attempts amid ongoing investigations.

Military forces ousted Guinea-Bissau's president and halted the country's electoral process this week before installing a general on Thursday to lead the country. With the motive for the coup not yet ...

Guinea Bissau Election In this photo released by the Communication office Presidency republic of Guinea Bissau, incumbent President Umaro Sissoco Embalo casts his votes at a polling station during the ...

Guinea-Bissau's deposed President Umaro Sissoco Embaló has arrived in neighbouring Senegal following his release by military forces that toppled his government this week, Senegal's authorities have ...

The US Department of Health and Human Services (HHS), led by Health Secretary Robert F. Kennedy Jr., in December 2025 announced a research project ...